Switzerland· 67313002
Dovato
A lamivudine and dolutegravir product containing lamivudinum, dolutegravirum, registered in Switzerland and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 13 of our 19 countries.
Checked against BAG Spezialitätenliste (Switzerland) on
Informational only — not a medical device.
Where it is registered
Lamivudine and dolutegravir is registered in 13 of 19 countries.
Countries holding a registration under ATC J05AR25 (lamivudine and dolutegravir), each read from that country’s own register.
- This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
- 8 of them publish a price we can compare per daily dose
Lamivudine and dolutegravir · ATC J05AR25
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
BAG Spezialitätenliste (Switzerland)- Active substance
- lamivudinum, dolutegravirum
- Manufacturer
- —
- Country
- Switzerland (CH)
- ATC code
- J05AR25
- ATC class
- Lamivudine and dolutegravir
- Swissmedic category
- A
- Reimbursed
- Yes
- Source register
- BAG Spezialitätenliste (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin7680673130025Blist 30 StkCHF 778.2
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lamivudine and dolutegravir in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaDOVATOViiV Healthcare BV, Amersfoort
- FinlandDovatoViiV Healthcare BV
- SpainDOVATO 50 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULAViiv Healthcare B.V.
- United KingdomDovato 50mg/300mg tabletsViiV Healthcare UK Ltd
- IrelandDovato 50 mg/300 mg tabletsViiV Healthcare BV
- IcelandDOVATOViiV Healthcare BV
- NetherlandsDovato 50 mg/300 mg filmomhulde tablettenViiV healthcare B.V.
- NorwayDovatoViiV Healthcare BV (1)
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Dovato
- Liechtenstein · Dovato
- Norway · Dovato
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/37b95589-f290-4d46-9194-27d590e8d437 GET /v1/drugs/37b95589-f290-4d46-9194-27d590e8d437?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "lamivudinum 300 mg + dolutegravirum 50 mg",
"valid_from": "2024-04-01",
"limitations": null,
"galenic_form": "Filmtabl 50/300 mg",
"therapeutic_area": null,
"sl_inclusion_date": "2024-04-01",
"self_retention_pct": 10
}See everything about lamivudine and dolutegravir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.